186 related articles for article (PubMed ID: 9350293)
1. Interleukin-10 response abnormalities in systemic lupus erythematosus.
Mongan AE; Ramdahin S; Warrington RJ
Scand J Immunol; 1997 Oct; 46(4):406-12. PubMed ID: 9350293
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B cell antibody synthesis.
al-Janadi M; al-Dalaan A; al-Balla S; al-Humaidi M; Raziuddin S
J Clin Immunol; 1996 Jul; 16(4):198-207. PubMed ID: 8840221
[TBL] [Abstract][Full Text] [Related]
3. Different monocyte reaction patterns in newly diagnosed, untreated rheumatoid arthritis and lupus patients probably confer disparate C-reactive protein levels.
Liou LB
Clin Exp Rheumatol; 2003; 21(4):437-44. PubMed ID: 12942694
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.
Llorente L; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Maillot MC; Durand-Gasselin I; Fourrier BM; Galanaud P; Emilie D
Eur Cytokine Netw; 1993; 4(6):421-7. PubMed ID: 8186374
[TBL] [Abstract][Full Text] [Related]
5. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.
Llorente L; Richaud-Patin Y; Fior R; Alcocer-Varela J; Wijdenes J; Fourrier BM; Galanaud P; Emilie D
Arthritis Rheum; 1994 Nov; 37(11):1647-55. PubMed ID: 7980676
[TBL] [Abstract][Full Text] [Related]
6. Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Gröndal G; Gunnarsson I; Rönnelid J; Rogberg S; Klareskog L; Lundberg I
Clin Exp Rheumatol; 2000; 18(5):565-70. PubMed ID: 11072595
[TBL] [Abstract][Full Text] [Related]
7. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
[TBL] [Abstract][Full Text] [Related]
8. Impaired production of IL-12 in systemic lupus erythematosus. I. Excessive production of IL-10 suppresses production of IL-12 by monocytes.
Liu TF; Jones BM
Cytokine; 1998 Feb; 10(2):140-7. PubMed ID: 9512904
[TBL] [Abstract][Full Text] [Related]
9. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus.
Scuderi F; Convertino R; Molino N; Provenzano C; Marino M; Zoli A; Bartoccioni E
Autoimmunity; 2003 Mar; 36(2):71-7. PubMed ID: 12820688
[TBL] [Abstract][Full Text] [Related]
10. Cytokine production (IL-6 and TNF alpha) in whole blood cell cultures of patients with systemic lupus erythematosus.
Swaak AJ; van den Brink HG; Aarden LA
Scand J Rheumatol; 1996; 25(4):233-8. PubMed ID: 8792800
[TBL] [Abstract][Full Text] [Related]
11. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Kanda N; Tsuchida T; Tamaki K
Arthritis Rheum; 1999 Feb; 42(2):328-37. PubMed ID: 10025928
[TBL] [Abstract][Full Text] [Related]
12. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients.
Fleischer V; Sieber J; Fleischer SJ; Shock A; Heine G; Daridon C; Dörner T
Arthritis Res Ther; 2015 Jul; 17(1):185. PubMed ID: 26183319
[TBL] [Abstract][Full Text] [Related]
13. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.
Llorente L; Zou W; Levy Y; Richaud-Patin Y; Wijdenes J; Alcocer-Varela J; Morel-Fourrier B; Brouet JC; Alarcon-Segovia D; Galanaud P; Emilie D
J Exp Med; 1995 Mar; 181(3):839-44. PubMed ID: 7869046
[TBL] [Abstract][Full Text] [Related]
14. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
al-Janadi M; Raziuddin S
J Rheumatol; 1993 Nov; 20(11):1885-91. PubMed ID: 7508509
[TBL] [Abstract][Full Text] [Related]
15. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
16. Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity.
Viallard JF; Taupin JL; Miossec V; Pellegrin JL; Moreau BL
Eur Cytokine Netw; 1999 Mar; 10(1):17-24. PubMed ID: 10210768
[TBL] [Abstract][Full Text] [Related]
17. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients.
Liou LB
Clin Exp Rheumatol; 2001; 19(5):515-23. PubMed ID: 11579710
[TBL] [Abstract][Full Text] [Related]
18. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
Sebbag M; Parry SL; Brennan FM; Feldmann M
Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
[TBL] [Abstract][Full Text] [Related]
19. Production of IL-1beta, IL-1 receptor antagonist and IL-10 by mononuclear cells from patients with SLE.
Andersen LS; Petersen J; Svenson M; Bendtzen K
Autoimmunity; 1999; 30(4):235-42. PubMed ID: 10524499
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus monocytes are less responsive to interleukin-10 in the presence of immune complexes.
Yuan W; DiMartino SJ; Redecha PB; Ivashkiv LB; Salmon JE
Arthritis Rheum; 2011 Jan; 63(1):212-8. PubMed ID: 20954190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
